CoChat

The DOI matches its Crossref record; 324 of the 330 references it cites were found in a registry or an index; 24 of the 49 sources its claims cite were checked for support.

Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections

Open access
Olie, Sabine E., Andersen, Christian Ø., van de Beek, Diederik, Brouwer, Matthijs C. · 2024 · Clinical Microbiology Reviews

Abstract

SUMMARYCentral nervous system (CNS) infections can be caused by various pathogens, including bacteria, viruses, fungi, and parasites. Molecular diagnostic methods are pivotal for identifying the different causative pathogens of these infections in clinical settings. The efficacy and specificity of these methods can vary per pathogen involved, and in a substantial part of patients, no pathogen is identified in the cerebrospinal fluid (CSF). Over recent decades, various molecular methodologies have been developed and applied to patients with CNS infections. This review provides an overview of the accuracy of nucleic acid amplification methods in CSF for a diverse range of pathogens, examines the potential value of multiplex PCR panels, and explores the broad-range bacterial and fungal PCR/sequencing panels. In addition, it evaluates innovative molecular approaches to enhance the diagnosis of CNS infections.

Overview

CoChat Summary

TL;DR

This review summarizes nucleic acid amplification testing (NAAT) in cerebrospinal fluid (CSF) for central nervous system (CNS) infections, covering pathogen-specific PCR, multiplex panels, broad-range PCR/sequencing, and metagenomic next-generation sequencing (mNGS). It reports generally high sensitivity and specificity for many pathogens but notes persistent diagnostic gaps, especially culture-negative cases and low-sensitivity assays such as those for *Mycobacterium tuberculosis*.

Key findings

  • For *Streptococcus pneumoniae*, CSF PCR sensitivity reached a median of 100% (range 79%–100%) and specificity a median of 98% (range 93%–100%); for *Neisseria meningitidis*, median sensitivity was 97% (range 91%–100%) and median specificity 96% (range 91%–100%), with PCR increasing cause-specific diagnosis by 13%–61% (median 59%) in culture-negative cases.
  • For *Haemophilus influenzae*, *bexA* PCR had median sensitivity 93% (range 81%–100%) and median specificity 94% (range 81%–100%); for *Mycobacterium tuberculosis*, IS6110 PCR had median sensitivity 91% (range 72%–100%) and median specificity 99% (range 82%–100%), while GeneXpert pooled sensitivity was 71% (95% CI 63–79) and Xpert Ultra sensitivity was 89% (95% CI 79–96).
  • For *Streptococcus suis* serotype 2, *cps2J* PCR showed 100% sensitivity (95% CI 97%–100%) and 100% specificity (95% CI 96%–100%), and adding PCR increased diagnostic yield by 84% in one population.
  • Multiplex PCR panels can detect multiple pathogens in one assay, but validation studies show both false-negative and false-positive results depending on the pathogen; broad-range 16S/18S/28S/ITS PCR/sequencing and mNGS offer unbiased detection but risk contamination and are not routine in most laboratories.

Methods

  • Design: narrative review of molecular diagnostics in CSF for CNS infections, including pathogen-specific NAAT, multiplex PCR panels, broad-range bacterial/fungal/parasitic PCR/sequencing, and mNGS.
  • Data/sample: published studies and validation cohorts of patients with suspected CNS infection, with reported sample sizes ranging from small case series (e.g., 3–6 patients for *Tropheryma whipplei* or *Brucella*) to larger cohorts (e.g., 827 patients with suspected bacterial meningitis for group B *Streptococcus* PCR).
  • Main analysis: qualitative synthesis of sensitivity, specificity, and incremental diagnostic yield compared with culture or conventional diagnostics, with results presented in tables and supplemental material.

Limitations

  • The paper states that PCR requires prior knowledge of the target sequence, is pathogen-specific, can produce false-positive results from DNA contamination, and can produce false-negative results when DNA concentration is too low; multiplex panels may yield false-positive and false-negative results depending on the pathogen.
  • The paper states that some pathogen-specific evidence is limited by small sample sizes and lack of adequately powered studies, such as for *Brucella* spp. and *Tropheryma whipplei*.
  • Evident from the text: the review is narrative and does not report a systematic search strategy, risk-of-bias assessment, or meta-analytic pooling in the available text; the provided text is also truncated, so later pathogen sections and conclusions are not available for summary.

Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/cmr.00021-24

Cites

324 of 324 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

11 Valid · 2 Not valid · 1 Not checked · 1 Own results and interpretations

  • It may state two separate claims as one. 10
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Citations

Cites

Show all 324 references

Research works printed but not linked: 1

  1. Anonymous. 2011. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO manual. 2nd ed. World Health Organization.

Cited by

See all 38

Metadata

Authors
Olie, S. E., Andersen, C. Ø., van de Beek, D., & Brouwer, M. C.
Affiliations
  • Amsterdam Neuroscience (NL)
  • Statens Serum Institut (DK)
  • Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience
Corresponding author
Brouwer, Matthijs C.
Venue
Clinical Microbiology Reviews
Published
2024-12-10
Volume
37
Issue
4
Pages
e0002124-e0002124
ISSN
  • 0893-8512 (ISSN-L)
  • 1098-6618
OpenAlex
W4403406701
Cited by
38
References
330
Citations by year
2026: 28 · 2025: 9 · 2024: 1
FWCI
2.10
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical Microbiology Reviews (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
Funders
EC | European Research Council (101001237)
Topics
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
central nervous system infection, cerebrospinal fluid, molecular diagnosis, nucleic acid amplification, multiplex PCR panels, pathogen identification, bacterial meningitis, viral meningitis, fungal meningitis, parasitic meningitis
MeSH terms
Bacteria, Central Nervous System Infections, Cerebrospinal Fluid, Humans, Viruses, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections. https://app.cochat.ai/papers/10.1128/cmr.00021-24
The paper
Olie, S. E., Andersen, C. Ø., van de Beek, D., & Brouwer, M. C. (2024). Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00021-24

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.